These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22924618)

  • 21. Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation.
    Sara GE; Large MM; Matheson SL; Burgess PM; Malhi GS; Whiteford HA; Hall WD
    Aust N Z J Psychiatry; 2015 Feb; 49(2):106-17. PubMed ID: 25518844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression.
    Che AM; Gomez RG; Keller J; Lembke A; Tennakoon L; Cohen GH; Schatzberg AF
    Psychiatry Res; 2012 Jun; 198(1):34-8. PubMed ID: 22410589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis of psychocognitive complaints or disorders after de novo consultation in a university hospital specialized memory unit].
    Thomas-Antérion C; Richard-Mornas A
    Rev Neurol (Paris); 2013 Feb; 169(2):97-107. PubMed ID: 22989782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use.
    Large M; Mullin K; Gupta P; Harris A; Nielssen O
    Aust N Z J Psychiatry; 2014 May; 48(5):418-32. PubMed ID: 24589980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between psychotic symptoms and substance use in young offenders.
    Degenhardt L; Coffey C; Hearps S; Kinner SA; Borschmann R; Moran P; Patton G
    Drug Alcohol Rev; 2015 Nov; 34(6):673-82. PubMed ID: 26084677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum level of venlafaxine is associated with better memory in psychotic disorders.
    Steen NE; Aas M; Simonsen C; Dieset I; Tesli M; Nerhus M; Gardsjord E; Mørch R; Agartz I; Melle I; Vaskinn A; Spigset O; Andreassen OA
    Schizophr Res; 2015 Dec; 169(1-3):386-392. PubMed ID: 26516101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosis in adulthood is associated with high rates of ADHD and CD problems during childhood.
    Dalteg A; Zandelin A; Tuninger E; Levander S
    Nord J Psychiatry; 2014 Nov; 68(8):560-6. PubMed ID: 24620816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-occurring psychotic and addictive disorders: neurobiology and diagnosis.
    Ross S; Peselow E
    Clin Neuropharmacol; 2012; 35(5):235-43. PubMed ID: 22986797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive markers of psychotic unipolar depression: a meta-analytic study.
    Zaninotto L; Guglielmo R; Calati R; Ioime L; Camardese G; Janiri L; Bria P; Serretti A
    J Affect Disord; 2015 Mar; 174():580-8. PubMed ID: 25560194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders.
    Singh S; Balhara YPS
    Indian J Med Res; 2017 Aug; 146(2):186-195. PubMed ID: 29265019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
    Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls.
    Amann B; Gomar JJ; Ortiz-Gil J; McKenna P; Sans-Sansa B; Sarró S; Moro N; Madre M; Landin-Romero R; Vieta E; Goikolea JM; Salvador R; Pomarol-Clotet E
    Psychol Med; 2012 Oct; 42(10):2127-35. PubMed ID: 22357405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of psychotic and nonpsychotic substance users in the psychiatric emergency room.
    Gilfillan S; Claassen CA; Orsulak P; Carmody TJ; Sweeney JB; Battaglia J; Rush AJ
    Psychiatr Serv; 1998 Jun; 49(6):825-8. PubMed ID: 9634166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exploration of research into substance misuse and psychiatric disorder in the UK: what can we learn from history?
    Crome IB
    Crim Behav Ment Health; 2007; 17(4):204-14. PubMed ID: 17902120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Traumatic life events and PTSD among women with substance use disorders and schizophrenia.
    Gearon JS; Kaltman SI; Brown C; Bellack AS
    Psychiatr Serv; 2003 Apr; 54(4):523-8. PubMed ID: 12663840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Homicide, schizophrenia and substance abuse: a complex interaction].
    Richard-Devantoy S; Bouyer-Richard AI; Jollant F; Mondoloni A; Voyer M; Senon JL
    Rev Epidemiol Sante Publique; 2013 Aug; 61(4):339-50. PubMed ID: 23816066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.